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Streszczenie
Wstęp: Stężenie osoczowe troponiny I (TnI) jest uznanym i po-
wszechnie stosowanym wskaźnikiem uszkodzenia mięśnia 
sercowego. 
Cel pracy: Określenie zależności pomiędzy osoczowymi stęże-
niami TnI a przebiegiem klinicznym z uwzględnieniem funkcji 
hemodynamicznej alograftu w pierwszych 4 dobach po prze-
szczepie serca (HTX).
Materiał i metody: Badaniem retrospektywnym objęto 54 pa-
cjentów (12–62 lat), u których wykonano HTX. Stężenia osoczowe 
TnI oznaczano w 4 kolejnych dobach po przeszczepie. Parametry 
hemodynamiczne mierzone były codziennie przy użyciu cewnika 
Swana-Ganza oraz echokardiografii. Liczba wymaganych w okre-
sie pooperacyjnym leków presyjnych również podlegała ocenie.
Wyniki: Wykazano silną dodatnią korelację pomiędzy średnim 
osoczowym stężeniem TnI a średnim zapotrzebowaniem na licz-
bę leków presyjnych (r = 0,51, p = 0,00). Pozytywną korelację za-
obserwowano również dla uśrednionych wartości ośrodkowego 
ciśnienia żylnego (CVP) (r = 0,33, p = 0,015). Wykazano słabą ten-
dencję w kierunku dodatniej korelacji pomiędzy średnią warto-
ścią ciśnienia zaklinowania w tętnicy płucnej (PCWP) a średnim 
osoczowym stężeniem TnI (r = 0,23, p = 0,09). Nie znaleziono 
istotnej korelacji pomiędzy średnim osoczowym stężeniem TnI 
a uśrednionymi wartościami frakcji wyrzutowej (EF) i rzutu ser-
ca (CO). Szczegółowa analiza wykazała istotną, dodatnią korela-
cję pomiędzy osoczowymi stężeniami TnI w 2. i 3. dobie po HTX 
a wartościami PCWP mierzonymi w dobach poprzedzających (od-
powiednio r = 0,32, p = 0,04; r = 0,46, p = 0,006). Ponadto zaob-
serwowano silną, ujemną korelację pomiędzy osoczowym stęże-
niem TnI w 2. dobie a CO w 3. dobie po HTX (r = –0,44, p = 0,03).
Wnioski: Stężenie osoczowe TnI może być użytecznym wskaź-
nikiem służącym do oceny funkcji hemodynamicznej prze-
szczepionego serca.
Słowa kluczowe: przeszczep serca, troponina I, parametry hemo-
dynamiczne.
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Abstract
Introduction: Plasma troponin I (TnI) concentration is a well-
established and widely-used marker of myocardial damage. 
Aim: To determine the correlation between TnI concentration 
measured within the first 4 days following heart transplanta-
tion (HTX) and clinical course, with consideration of hemody-
namic performance. 
Material and methods: The retrospective study included 54 pa- 
tients (12-62 years) who underwent HTX. TnI levels were as-
sessed over the first 4 post-operative days. Hemodynamic 
parameters were assessed daily at Swan-Ganz catheterization 
and echocardiography. The number of required inotropic drugs 
was also analyzed.
Results: There is a strong and positive correlation between the 
mean TnI levels and the mean number of required inotropic 
drugs (r = 0.51, p = 0.00), and also mean central venous pres-
sure (CVP) (r = 0.33, p = 0.015). A weak trend towards a posi-
tive correlation between the mean values of pulmonary capil-
lary wedge pressure (PCWP) and the mean plasma TnI levels 
was observed. There was no correlation between mean TnI 
levels and mean values of ejection fraction (EF) and cardiac 
output (CO). Detailed analysis showed a statistically signifi-
cant correlation between TnI levels on days 3 and 4 after HTX 
and PCWP on the preceding days (r = 0.32, p = 0.04; r = 0.46, 
p = 0.006 respectively). Furthermore, a strong, inverse correla-
tion between TnI levels on day 3 and CO on day 4 following 
HTX was observed (r = –0.44, p = 0.03).
Conclusions: Plasma TnI could be a useful marker for assess-
ing the hemodynamic function after HTX.
Key words: heart transplantation, troponin I, hemodynamic 
parameters.
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Introduction
Heart transplantation (HTX) is the ultimate and ac-
cepted treatment option in patients with end-stage heart 
failure (if other treatments fail). In the newest ESC (Euro-
pean Society of Cardiology) guidelines it remains the gold-
standard treatment with acceptable, long-term survival. 
The recent ISHLT (International Society for Heart and Lung 
Transplantation) registry shows a half-life time (the time 
for which 50% of patients survived) of more than 10 years.
According to the ESC guidelines, HTX significantly im-
proves survival, physical capacity, and quality of life [1, 2].
Nevertheless, the donor shortage, which limits heart 
transplants, is difficult to eliminate. The number of heart 
transplants performed each year has not increased and 
there has been a reduction observed worldwide in recent 
years. The ISHLT Registry shows that in Europe the number 
of heart transplants has decreased by over 40% over the 
last two decades [2].
Undoubtedly, this fact affects the condition of recipi-
ents, as it prolongs the waiting time. Facing reality we have 
to admit that nowadays, qualification for HTX is reserved 
almost exclusively for urgent patients [3, 4]. Criteria for 
qualifying patients for HTX on the high-urgency (HU) list 
are presented on the official POLTRANSPLANT website [3].
As we conclude from our clinical experience, patients 
who are qualified for HTX urgently, suffer from a more 
eventful postoperative course compared to non-urgent pa-
tients. Similar outcomes were observed by Haneya et al., 
whose research showed markedly increased prevalence of 
comorbid conditions and rate of secondary organ impair-
ment in patients waiting for HTX on the high-urgency list 
[5]. Additionally to the circumstances described above, the 
necessity to accept marginal donors makes the postopera-
tive course even more difficult.
Considering the current situation, searching for poten-
tial markers which will be potent to demonstrate the injury 
of the allograft is crucial to reduce the risk of postoperative 
complications.
In our study we decided to conduct an analysis of tro-
ponin I (TnI) as such biomarker. As we concluded from our 
previous studies and according to other research performed 
worldwide, significantly elevated troponin I levels can be ob-
served immediately after heart transplantation. That could 
demonstrate perioperative injury connected with harvest-
ing and implanting the heart. However, reports on the re-
lationship between troponin levels and the postoperative 
course over the first days following HTX are few [6-11].
Aim of the study
The purpose of the present study was to assess the re-
lationship between troponin I levels measured over the first 
few days after HTX and the hemodynamic function of the 
transplanted heart.
Material and methods
The retrospective analysis included 54 patients (5 fe-
males, 49 males) aged 12-62 years (median age: 52, IQR = 15).
The inclusion criteria in this study were as follows: 
1. Availability of troponin I levels measured over the first 
days after HTX (from day 1 to day 4). Troponin I levels were 
measured using the one step immunoenzymatic assay 
(SIEMENS, Germany, normal range below 0.1 ng/ml). 2. Do-
nor hearts procured using the same standard techniques 
and the same cardioplegic solution (CELSIOR) in a volume 
of 4 liters (heart procurement and graft protection were de-
scribed in our pilot study) [6].
All patients operated on in the Department of Cardio-
vascular Surgery and Transplantology, Institute of Cardi-
ology, Jagiellonian University College of Medicine at John 
Paul II Hospital in Krakow and meeting the inclusion crite-
ria were included in the analysis (changes in the methodol-
ogy and type of measured troponin were the most impor-
tant factors limiting the size of the study group).
Function of the transplanted heart was evaluated daily 
with assessment of:
• echocardiographic parameters – measurements were 
performed using GE Vivid I and GE Vivid 7; left ventricle 
ejection fraction (LVEF) was assessed using semi-quanti-
tative measurement verified with the biplane Simpson’s 
method,
• hemodynamic parameters – pulmonary capillary wedge 
pressure (PCWP), central venous pressure (CVP) – were 
evaluated invasively at the ICU using a Swan-Ganz cath-
eter; measurements of cardiac output (CO) were per-
formed using the bolus thermodilution procedure; the 
mean value estimated from 3 successive measurements 
was considered as the final result of the test,
• inotropic support – need for routinely used inotropic 
drugs (adrenaline, dobutamine, norepinephrine and the 
phosphodiesterase type 5 inhibitor milrinone) – was as-
sessed, based on quantitative evaluation of the number 
of administered drugs.
In case of more than one measurement per day, the 
highest value of TnI, CVP, PCWP and the lowest value of CO 
and EF were introduced into the analysis. Mean values of 
above-listed parameters measured over 4 days were ana-
lyzed for correlations using statistical methods. If no corre-
lation was found, further detailed analysis of the data was 
performed.
Statistical analysis
Analyses were performed using STATISTICA v. 10 soft-
ware (StatSoft, Inc.). Continuous variables were assessed 
for normal distribution using the Shapiro-Wilk test. Data 
were presented as mean and standard deviation (SD) or 
median and interquartile range (IQR) as appropriate. To 
assess the relationship between non-normally distribut-
ed variables, Spearman’s rank correlation coefficient test 
(Spearman’s rho) was calculated. A p-value of ≤ 0.05 was 
considered statistically significant.
Results
Over the first consecutive days after HTX, troponin I 
levels were elevated, reaching a maximum median value 
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of 17.08 ng/ml on day 2 (Troponin II) (Table I). A strong posi-
tive correlation was established for the mean plasma TnI 
levels and the mean number of required inotropic drugs at 
a statistically significant level (r = 0.51, p = 0.00) (Fig. 1). 
There was also a positive correlation between mean plasma 
TnI levels and mean CVP (r = 0.33, p = 0.015) (Fig. 2). A weak 
trend towards a positive correlation between mean values 
of PCWP and the mean plasma TnI levels on the borderline 
of statistical significance was observed (r = 0.23, p = 0.09) 
(Fig. 3). However, a detailed analysis showed a significant pos-
itive relationship between TnI levels on day 3 and PCWP on 
day 2 (r = 0.32, p = 0.043), as well as between TnI levels on 
day 4 and PCWP on day 3 following HTX (r = 0.46, p = 0.006). 
Despite the fact that there was no relationship between 
mean plasma TnI concentrations and the mean values of EF 
and CO, we found a strong, statistically significant, inverse 
correlation between TnI levels on day 3 and CO on day 4 
(r = –0.44, p = 0.03).
Discussion
Cardiac troponins are the most specific and sensitive 
laboratory markers of myocardial cell injury. Since the heart 
transplantation procedure is associated with many factors 
that can cause damage to the myocardium, plasma tro-
ponin concentrations are usually markedly elevated during 
the postoperative period [6, 9, 11]. Although troponin levels 
are usually assessed following HTX, their role and signifi-
cance are not fully determined yet.
There is some evidence confirming usefulness of their 
evaluation as a tool for prognosticating outcomes of trans-
planted patients. Our previous analyses established a sig-
nificant relationship between troponin levels and clinical 
course early after HTX [6, 7]. Some papers underline the 
relation between troponin level and the risk of allograft 
rejection or ischemic damage of myocardium in the early 
postoperative period [12, 13]. Other studies have revealed 
the important role of troponins in predicting long-term sur-
vival. Erbel et al. found a major impact of troponin release 
in 6 weeks after HTX on 1 year survival [14]. In 2000 Labar-
rere et al. published follow-up results of 110 graft recipi-
ents. They found significantly higher incidence of coronary 
artery disease (vasculopathy) and graft failure at 5 years 
following HTX among patients with persistently elevated 
Tab. I. Median troponin I levels measured over first consecutive 
days following HTX
Median qr
Troponin I 16.9 9.9
Troponin II 17.08 11.2
Troponin III 11.6 13
Troponin IV 7.61 8.1
120
100
80
60
40
20
0
–20
M
ea
n 
bl
oo
d 
tr
op
on
in
 I 
le
ve
l [
ng
/m
l]
 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5
Mean number of inotropic drugs required
R-Spearman = 0.51
p = 0.00
Fig. 1. Correlation between mean plasma troponin I concentra-
tion and mean number of required inotropic drugs measured over 
4 days after heart transplantation (R-Spearman – Spearman rank 
correlation coefficient)
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Fig. 2. Correlation between mean plasma troponin I concentration 
and mean value of central venous pressure measured over 4 days 
after heart transplantation (R-Spearman – Spearman rank corre-
lation coefficient)
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Fig. 3. Interdependence between mean plasma troponin I concen-
tration and mean value of pulmonary capillary wedge pressure 
measured over 4 days after HTX – statistical trend (R-Spearman 
– Spearman rank correlation coefficient)
Kardiochirurgia i Torakochirurgia Polska 2014; 11 (3)292
Does the postoperative troponin I blood concentration measured in the perioperative period… 
troponin I levels during one year after HTX compared with 
those with undetectable troponins over the first month fol-
lowing HTX [10].
In this study we decided to analyze the correlation be-
tween mean plasma troponin I levels measured in the first 
4 postoperative days and hemodynamic function of trans-
planted heart. We analyzed EF, CO, CVP, and PCWP, as these 
parameters are routinely used to recognize left and right ven-
tricle dysfunction and to diagnose primary graft failure (PGF), 
which is the main cause of early mortality in transplanted 
patients. According to the 2013 ISHLT annual report, PGF ac-
counts for 36% of deaths within 30 days after HTX [8, 15]. 
Thus, knowledge of risk factors and symptoms is crucial for 
immediate diagnosis and treatment of this condition.
Although there is no universally accepted clinical defi-
nition of PGF, it can be described as severe systolic dys-
function of the graft and severe hemodynamic compro-
mise without any obvious anatomic or immunologic cause 
leading to low output syndrome (LOS), which requires 
high-dose inotropic or mechanical support. The diagnosis 
is performed based on commonly assessed hemodynamic 
parameters [8].
Echocardiographic measurements of the RVEF and LVEF 
were defined in Siniawski’s research as the most useful in 
distinguishing between PGF and other, less fatal, aberra-
tions [16]. Similar results were concluded from the research 
by D’Alessandro et al., who determined LVEF < 55% as 
a predictive factor for primary graft failure (PGF) [17].
In our study we did not find any substantial influence 
of mean plasma troponin I levels measured in the first 
4 days after HTX on LVEF or on CO. It is probably because 
of the fact that in patients with failing systolic function of 
the heart, more powerful inotropic support was applied. 
However, a statistically significant correlation between TnI 
level measured on day 3 and CO measured on day 4 was 
observed. Taking into account the small size of the study 
group, this fact should encourage further investigation of 
the relationship between the two variables, as this result 
suggests that elevation of TnI level may overtake exacerba-
tion of LV systolic function.
In the analysis of hemodynamic function of the trans-
planted heart we also included CVP and PCWP, as these pa-
rameters are routinely measured in order to describe right 
(CVP) and left (PCWP) ventricle dysfunction. In previously 
mentioned research by Siniawski, CVP and PCWP were also 
assessed in order to recognize PGF, although interdepend-
ence with troponin levels was not established [16].
Our research revealed a positive correlation between 
mean plasma troponin I levels and mean CVP. We could also 
observe a statistical trend towards higher values of mean 
PCWP in patients with elevated mean plasma TnI concen-
tration (r = 0.23, p = 0.09). In view of the fact that detailed 
analysis revealed two cases of a statistically significant cor-
relation between PCWP and TnI (see the results), the trend 
is becoming more relevant and deserves scrutiny.
Standard treatment of PGF comprises routine use of 
moderate- to high-dose inotropic agents and, in more se-
vere cases, mechanical circulatory support (IABP, ECMO) 
[18]. The intensity of inotropic support is usually combined 
with a higher incidence rate of PGF [8].
Our study analyzed the correlation between average 
troponin I levels and requirement for inotropic support and 
a statistically significant influence was found – more ino-
tropic drugs need to be introduced in patients with higher 
troponin I levels.
In summary, our research demonstrates troponin as 
a significant and valuable parameter which could influence 
the postoperative course. Troponin I measurements per-
formed on a daily basis might be useful in anticipating and 
monitoring the potential failure of a transplanted heart.
According to our best knowledge, there are no papers 
investigating similar correlations. The present study, which 
should be considered as preliminary, reveals statistically 
proven effects of troponin I levels measured over the first 
days after HTX on the hemodynamic function of the trans-
planted heart. Nevertheless, the small size of the study 
group does not allow any definite conclusions, and another 
study should be conducted to finally confirm our results.
The limitations of the study were the retrospective anal-
ysis of the data, small sample size, and statistical analysis 
based on non-parametric tests.
Conclusions
Marked elevation of plasma troponin I levels observed 
early after heart transplantation influence the hemody-
namic function of the transplanted heart. Mean troponin 
I levels measured over the first 4 days after HTX posi-
tively correlated with: 1) mean central venous pressure 
(p = 0.015), 2) mean pulmonary capillary wedge pressure 
(statistical trend) (p = 0.09), 3) mean requirement for ino-
tropic drugs (p = 0.00) in the analogical period.
Detailed analysis also revealed correlations between: 
1) TnI level on day 3 with CO on day 4 (p = 0.03) and 
2) PCWP on day 2 with TnI on day 3 and PCWP on day 3 with 
TnI on day 4 (p = 0.00).
Troponin I levels should be considered as an easily as-
sessed marker of graft dysfunction. However, it requires 
further confirmation. We recommend troponin I evaluation 
on a daily basis during the first days following HTX.
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